All Articles

Johnson & Johnson's massive investment in Jacksonville promises economic growth, but the real story is a strategic pivot to secure the U.S. healthcare supply chain.

A class action alleges catastrophic data failures at Canada's tax agency, costing families thousands and exposing a potential billion-dollar liability.

LONGi celebrates a massive solar milestone, but with industry margins squeezed, we analyze if its high-efficiency bet can deliver long-term value.

A bitter proxy fight erupts at Fermi Inc., pitting its founder against the board. At stake is not just the company, but its ambitious AI power grid project.

The collateral management firm appoints a new CPO and promotes key execs, signaling a foundational shift to build autonomous AI-native products.

For 20 years, Montreal's Segal Cancer Centre has quietly built a world-class innovation engine. We dissect its unique model where research, care, and funding converge.

Praecipio's new financing arm aims to break budget logjams for Atlassian users, but does this model create new dependencies and hidden financial risks?

With audited reserves and public funds, exchanges are pushing for transparency. We dive deep into whether this new model for accountability can truly secure your assets.

A new partnership between Argonaut and Ensera aims to untangle complex supply chains for drug-device products, potentially leveling the field for smaller innovators.

A new partnership aims to move beyond static risk models by integrating real-time news sentiment, giving firms a crucial edge in navigating market volatility.

Amid rising cyber threats, Toobit launches a security hub with verifiable Proof of Reserves. But does this bet on transparency truly redefine trust?

The graduation of Hemlo Mining to the TSX is more than a financial footnote. It's a story of strategic revitalization for a legendary Canadian gold camp.

China's Atom Therapeutics is advancing a dual-threat pipeline, with novel drugs for gout and a groundbreaking anti-inflammatory aimed at cardiovascular disease.

Amid a frenzied market for drill rigs, Eminent Gold begins a pivotal program in Nevada. It's a story of high-tech exploration and strategic patience.

Skanska's massive Karlstad hospital project promises a high-tech future, but can a building solve deep-seated healthcare system challenges like staff shortages?

A new pact between BioSTL and the UK's NHS is set to make St. Louis a prime U.S. launchpad for health tech, turning global innovation into local impact.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

With new drinks, TaylorMade merch, and John Daly, Dunkin's golf campaign is a lesson in modern branding. It's about selling an identity, not just a product.

Fortuna's key environmental win in Senegal de-risks its Diamba Sud gold mine, highlighting the nation's push for responsible resource development.

Colorado's lottery modernization is a major commercialization win for Pollard Banknote, signaling a new era of digital engagement and revenue for state programs.